These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 1581913
1. The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Borg A, Zhang QX, Alm P, Olsson H, Sellberg G. Cancer Res; 1992 May 15; 52(10):2991-4. PubMed ID: 1581913 [Abstract] [Full Text] [Related]
4. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer. Bièche I, Lidereau R. Mol Carcinog; 2000 Nov 15; 29(3):151-8. PubMed ID: 11108660 [Abstract] [Full Text] [Related]
5. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus. Dodson MK, Cliby WA, Xu HJ, DeLacey KA, Hu SX, Keeney GL, Li J, Podratz KC, Jenkins RB, Benedict WF. Cancer Res; 1994 Feb 01; 54(3):610-3. PubMed ID: 8306318 [Abstract] [Full Text] [Related]
8. Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression. Kim TM, Benedict WF, Xu HJ, Hu SX, Gosewehr J, Velicescu M, Yin E, Zheng J, D'Ablaing G, Dubeau L. Cancer Res; 1994 Feb 01; 54(3):605-9. PubMed ID: 8306317 [Abstract] [Full Text] [Related]
9. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P. Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152 [Abstract] [Full Text] [Related]
10. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Yoo GH, Xu HJ, Brennan JA, Westra W, Hruban RH, Koch W, Benedict WF, Sidransky D. Cancer Res; 1994 Sep 01; 54(17):4603-6. PubMed ID: 8062250 [Abstract] [Full Text] [Related]
11. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity. Jares P, Campo E, Pinyol M, Bosch F, Miquel R, Fernandez PL, Sanchez-Beato M, Soler F, Perez-Losada A, Nayach I, Mallofré C, Piris MA, Montserrat E, Cardesa A. Am J Pathol; 1996 May 01; 148(5):1591-600. PubMed ID: 8623927 [Abstract] [Full Text] [Related]
14. Mutation spectrum of the retinoblastoma gene in osteosarcomas. Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki MS, Kotoura Y, Yamamuro T. Cancer Res; 1994 Jun 01; 54(11):3042-8. PubMed ID: 8187094 [Abstract] [Full Text] [Related]
15. Expression of retinoblastoma protein in human breast cancer: an immunohistochemical study. Bianchi S, Calzolari A, Giannelli E, Giordano A, Zampi G. Pathologica; 1994 Apr 01; 86(2):146-9. PubMed ID: 7936756 [Abstract] [Full Text] [Related]
16. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation. Kittiniyom K, Mastronardi M, Roemer M, Wells WA, Greenberg ER, Titus-Ernstoff L, Newsham IF. Genes Chromosomes Cancer; 2004 Jul 01; 40(3):190-203. PubMed ID: 15138999 [Abstract] [Full Text] [Related]
17. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Toguchida J, Ishizaki K, Sasaki MS, Ikenaga M, Sugimoto M, Kotoura Y, Yamamuro T. Cancer Res; 1988 Jul 15; 48(14):3939-43. PubMed ID: 2898286 [Abstract] [Full Text] [Related]
18. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. Reissmann PT, Koga H, Takahashi R, Figlin RA, Holmes EC, Piantadosi S, Cordon-Cardo C, Slamon DJ. Oncogene; 1993 Jul 15; 8(7):1913-9. PubMed ID: 8390038 [Abstract] [Full Text] [Related]